Key Drivers
- High margins
- Strong FCF
- Intangible concentration
AIAI Summary
HealthEquity has shifted from an account‑growth story to a cash‑and‑margin story where upside now hinges on custodial yield normalization driving sustainable margin expansion and FCF conversion rather than multiple expansion from account growth. Investors should watch custodial yields, margin cadence, and management's capital allocation (buybacks/M&A) as the key catalysts/risks, with margin rollback or sizable intangible impairments likely to trigger quick multiple compression — downside if price falls below the 75.6–75.9 support cluster.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High margins
- •Strong FCF
- •Intangible concentration
HQY delivers strong liquidity, high margins and robust free cash flow but trades at a premium with sizeable intangible-assets risk that could amplify downside.
Price Behavior
Key Price Behavior Insights:
- •Above last month SMA
- •Neutral momentum
- •Range-bound action
HQY is trading above its last month SMA (~$78.50) within a contained $75.60–$81.15 range, with a neutral RSI (~48) implying modest upside potential but limited momentum and risk of a drop if support fails.
Earlier large drawdowns this year increase tail-risk if support breaks
Sentiment & News
Key News Insights:
- •Record revenue/profits
- •Custodial yield tailwind
- •Mixed analyst reactions
HealthEquity beat Q4 estimates with record revenue and a 123% jump in net income—driven by higher custodial yields and HSA growth—prompting higher FY27 outlooks amid mixed analyst responses and active institutional rebalancing.
Clearer earnings visibility and margin expansion should support the stock, though upside may be tempered by analyst caution and portfolio rebalances
Similar Companies in Healthcare
Other companies in the same sector with AI ratings